Company News: Page (1) of 1 - 09/20/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27

(September 20, 2017)

ZUG, Switzerland, Sept. 20, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that Thomas Meyer, Ph.D., Chairman and Chief Executive Officer, will present at the LEERINK Partners Rare Disease Roundtable Series in New York City on Wednesday, September 27, 2017, at 9:30 a.m. Eastern Time. A live webcast of the event will be available through the Events and Presentations page in the Investors section of the Auris Medical website at, and a replay of the presentation will be available following the event.

Page: 1

Related Keywords:


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved